Search Results 1351-1360 of 18134 for monoclonal antibody
... monoclonal antibodies per center standard of care. Must be up-to-date on cancer screening according to site-specific guidelines and past medical history ...
The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...
Convalescent Plasma: A Therapy for COVID-19? Kate Ledger. April 6, 2020. Science Saturday: The importance of antibody testing in addressing COVID-19 featured ...
Anti-nuclear antibody (ANA) - negative or ≤ normal institutional range ... monoclonal antibodies, small molecule inhibitors) for this cancer; Known ...
... antibodies in your blood samples. The biomarker and antibody results along with your personal medical profile will be evaluated to determine your risk for ...
Known hypersensitivity to another monoclonal antibody that cannot be controlled with standard measures (e.g., antihistamines and corticosteroids) or known ...
Has had a prior anti-cancer monoclonal antibody within 4 weeks prior to ... Has a known history of HIV (HIV 1/2 antibodies). Has known active Hepatitis ...
... monoclonal antibody (mAb) with a Vascular endothelial growth factor (receptor) tyrosine kinase inhibitor (VEGFR-TKI) or a PD-1 targeting mAb with a CTLA-4 ...
Other monoclonal antibodies, antibody-drug conjugates, radioimmunoconjugates, or experimental therapies: ≤4 weeks (≤3 weeks with documented disease ...
Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.